本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。CAR-T因惊奇的疗效,曾一度成为资本市场的宠儿。然而,这项技术在产业化落地过程中,却遭遇诸多问题,资本也因此逐渐意兴阑珊。很长一段时间中,国内资本市场几乎听不到CAR-T企业融资的消息,整个产业犹如遭遇“寒冰”冻结。山重水复疑无路,柳暗花明又一村。在市场情绪最低落的时候,事情却悄然发生转机,艺妙神州、科济药业纷纷在近期宣布完成CAR...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.